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Abstract Pimaricin (natamycin) is a small polyene macrolide
antibiotic used worldwide. This efficient antimycotic and
antiprotozoal agent, produced by several soil bacterial species
of the genus Streptomyces, has found application in human
therapy, in the food and beverage industries and as pesticide.
It displays a broad spectrum of activity, targeting ergosterol
but bearing a particular mode of action different to other poly-
ene macrolides. The biosynthesis of this only antifungal agent
with a GRAS status has been thoroughly studied, which has
permitted the manipulation of producers to engineer the bio-
synthetic gene clusters in order to generate several analogues.
Regulation of its production has been largely unveiled, con-
stituting a model for other polyenes and setting the leads for
optimizing the production of these valuable compounds. This
review describes and discusses the molecular genetics, uses,
mode of action, analogue generation, regulation and strategies
for increasing pimaricin production yields.
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Introduction
Pimaricin (PIM), also called natamycin, tennecetin, natacyn
and E235, is a natural product produced by given members of
the genus Streptomyces, a class of filamentous soil-dwelling
bacteria that undergo a complex life cycle involving differen-
tiation and sporulation. It belongs to the polyene class of
macrolide polyketides, and displays a strong and broad spec-
trum mould inhibition activity, yet being safe and effective at
very low concentrations. Because its molecular target is ergos-
terol, an essential constituent of fungal membranes, and bac-
teria do not contain sterols in their membranes, it is inactive
against bacteria. For the same reason, it is extremely reluctant
to microbial resistance since the only way fungi would have to
evade its action would be to change sterols from their mem-
branes. For these reasons, and because of its low toxicity to
mammalian cells, this molecule has become one of the major
mould inhibitors used in the food industry. Its use was ap-
proved in 1967 as a cheese preservative, and since then, it
has been extended to a wide variety of foods and beverages.
In addition, PIM has been regarded as the most important
agent in the management of fungal keratitis, a leading cause
of blindness in corneal diseases, which is relatively common
in warm climates and developing countries. Furthermore, it is
also used as a crop protection agent to prevent mould contam-
ination. Besides its antifungal action, it is also active against
protozoa having ergosterol in their membranes.
Useful reviews about polyene macrolide biosynthesis and
analogue generation are available in the literature (Aparicio
et al. 2003; Aparicio et al. 2004; Caffrey et al. 2008; Kong
et al. 2013). This mini-review provides a general view of the
applicability of PIM, describes its particular mode of action
and highlights the recent advances in the molecular genetics
and metabolic engineering of its biosynthetic pathway to pro-
duce PIM derivatives with enhanced properties. It also
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provides important insights about the considerable progress
attained in recent years aimed to unveil the complex network
of regulators involved in its biosynthesis and discusses differ-
ent strategies for increasing production yields.
Discovery and structure
PIM is a small-sized polyene antibiotic. Its name derives from
the South African region of Natal (‘Christmas’ in Portuguese,
Vasco da Gama having landed on its shores on 25 December
1497), where the first producing strain, Streptomyces
natalensis, was isolated (Struyk et al. 1957-1958). In addition,
other strains like S. gilvosporeus , S. lydicus and
S. chatanoogensis have also been identified as PIM producers.
Its structural core is a 26-membered macrolactone ring with
four conjugated double bonds (chromophore) (Fig. 1). Its
tetraene nature was unveiled shortly after its discovery
(Patrick et al. 1958), but its correct covalent structure was
not solved until 1966 (Golding et al. 1966) and its stereochem-
ical structure some 24 years later (Lancelin and Beau 1990).
More recently, its solution NMR structure has been described
(Volpon and Lancelin 2002). Like most glycosylated poly-
enes, its molecule contains a mycosamine (3-amino-3,6-
dideoxy-D-mannose) moiety linked to the macrolactone ring
via a β-glycosidic bond at C15. In the aglycone, the most
characteristic features are the presence of an epoxide group
at C4-C5, which originates from a double bond (Mendes
et al. 2001, 2005); an exocyclic carboxyl function at C12 that
derives from a methyl group (Caffrey et al. 2008; Martín and
Aparicio 2009; Qi et al. 2015; Liu et al. 2015b); and an internal
hemiketal ring resulting from spontaneous cyclisation between
a keto group at C9 and a hydroxyl group at C13 (Aparicio et al.
2000) (Fig. 1). Because of the presence of the chromophore in
its structure, PIM shows characteristic physicochemical prop-
erties, including a strong UV-visible light absorption and
photolability. The UV-visible light absorption spectrum of
PIM shows a characteristic shape due to its multipeak pattern
(Fig. 1). Like in all polyenes, the chromophore is located op-
posite to a number of hydroxyl functions, making PIM strong-
ly amphipathic, the region where the chromophore lies has a
planar and rigid lipophilic nature, whilst the hydroxylated re-
gion is typically flexible and hydrophilic (Bolard 1986). This
feature allows the molecule to interact with the sterol mole-
cules present in fungal cell membranes (predominantly ergos-
terol), by means of hydrophobic interactions between the hy-
drophobic portion of the polyene and the sterol, which results
in cell death (Aparicio et al. 2004).
Because of its amphiphilic nature, it is poorly soluble in
water and almost insoluble in non-polar solvents. As a pow-
der, it is stable in the dark, with no loss of activity, but it is
light sensitive in aqueous suspensions. Its CAS number is
7681-93-8.
Bioactivity
PIM has a strong antifungal activity on most fungi (mini-
mal inhibitory concentrations are in the micromolar range).
For many years, it was thought that its mode of action on
Fig. 1 Structures of PIM and its
target ergosterol. The UV-visible
absorption spectrum of PIM is
also included
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fungal membranes was to act as a permeabilising agent, as
occurs with other polyenes (Bolard 1986). However, in
clear contrast to large glycosylated polyenes like nystatin
or amphotericin B that kill fungi by forming ion-permeable
pores upon binding to ergosterol (Fujii et al. 1997;
Baginski et al. 1997, 2006), or to the small polyene filipin
which lacks the mycosamine moiety and also the carboxyl
group, and is thought to interact with sterols by forming a
sandwich-like structure embedded within the hydrophobic
core of the lipid bilayer, which results in membrane frag-
mentation and cellular leakage (de Kruijff and Demel
1974; Knopik-Skrocka and Bielawski 2002), PIM blocks
fungal growth by binding specifically to ergosterol but
without permeabilising the membrane (te Welscher et al.
2008).
Thus, unlike other polyene antibiotics, PIM does not
seem to formmembrane disruption complexes and its action
must be correlated with the alteration of the normal func-
tioning of ergosterol in the fungal membrane. Ergosterol is
the principal sterol in fungal cells, and has been correlated
with multiple functions, including endocytosis, exocytosis,
vacuole fusion, polarity and morphogenesis (Munn 2001;
Kato andWickner 2001; Heese-Peck et al. 2002; Martin and
Konopka 2004; Wachtler and Balasubramanian 2006;
Mysyakina and Funtikova 2007; Takeshita et al. 2008; Jin
et al. 2008). Recently, Van Leeuwen et al. (2009) have prov-
en that PIM inhibits endocytosis in germinating conidia of
Penicillium discolor without causing extensive cell damage
(i.e. without membrane permeabilisation), and Breukink
and his group have also found that PIM impairs vacuole
fusion via perturbation of ergosterol-dependent priming re-
actions that precede membrane fusion (te Welscher et al.
2010). Given that the priming phase consists solely on pro-
tein rearrangements, they pointed out to a more general
mode of action such as the disturbance of ergosterol-
dependent protein functions (te Welscher et al. 2010). This
hypothesis was demonstrated only 2 years later, when they
proved that PIM inhibits growth of yeasts and fungi via the
immediate inhibition of amino acid and glucose transport
across the plasma membrane by an ergosterol-dependent
inhibition of transport proteins (te Welscher et al. 2012).
Because its molecular target is ergosterol, a structural con-
stituent of fungal membranes, PIM, is extremely unlikely to
provoke microbial resistance (Aparicio et al. 2004).
Besides its antifungal action, PIM has been involved in
the immune response activation by triggering interleukin-
1β secre t ion th rough ac t iva t ion of the NLRP3
inflammasome (Darisipudi et al. 2011). The mechanism
of activation relies on the induction of potassium efflux
from the cells as well as on phagocytosis-dependent lyso-
some destabilisation. This suggests that besides inhibiting
fungal growth directly, it may also suppress fungal growth
indirectly via activating innate host defence.
Additionally, this polyene has also been found to be active
‘in vitro’ against several protozoa such as Trypanosoma
(Rolón et al. 2006) or Acanthamoeba (Sunada et al. 2014).
These organisms have ergosterol-derived compounds as com-
ponents of their membranes, making PIM or its derivatives
also potentially useful as antiparasitic agents.
Applications
Therapy
PIM has found clinical application as a topical agent in the
treatment of various fungal infections, including oral, intesti-
nal or vulvovaginal candidiasis (Cevher et al. 2008). But the
most important playground for PIM is in the treatment of
ophthalmic mycoses. PIM was the first antifungal agent ap-
proved by the Food and Drug Administration (FDA) of the
United States (in 1978); it can be used for the treatment of
fungal blepharitis, conjunctivitis, scleritis and endophthalmitis
(Thomas 2003) and constitutes the first-line treatment in fun-
gal keratitis (Ansari et al. 2013). It possesses activity against a
great variety of yeast and filamentous fungal pathogens, in-
c luding Al ternar ia , Candida , Cephalospor ium ,
Colletotrichum, Curvularia, Lasiodiplodia, Scedosporium,
Trichophyton and Penicillium spp. (Kaliamurthy et al. 2004;
Thomas and Kaliamurthy 2013; Hsiao et al. 2014), and is
currently considered the most effective medication against
Fusarium and Aspergillus (Lalitha et al. 2007). Additionally,
PIM is also effective for the treatment of keratitis produced by
protozoa such as Acanthamoeba (Sunada et al. 2014).
Food
Because of its broad spectrum of activity, its low likelihood of
causing microbial resistance and especially its low toxicity to
mammalian cells (Arima et al. 2014), PIM has been widely
used as a food preservative for more than 40 years (Fig. 2). It
is significantly more effective than sorbate, another common-
ly used antifungal preservative (Shibata et al. 1991; Pipek
et al. 2010). When applied on the surface of foods, it does
not affect its organoleptic properties (taste, texture and col-
our), and has prolonged antimicrobial activity, being safe for
consumption because its oral absorption is negligible (Juneja
et al. 2012). It has been authorised by the European Food
Safety Authority (EFSA) (additive E235), the World Health
Organisation (WHO) and the FDA for protecting foods from
yeast and mould contamination and possible inherent risks of
mycotoxin poisoning. Notably, it is the only antifungal agent
with a generally regarded as safe (GRAS) status.
Since bacterial membranes are devoid of sterols, PIM is not
active against bacteria, thus making it an ideal antimicrobial
during bacterial ripening and fermentation processes for
fermented foods. Thus, it has been traditionally used as a
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preservative in cheese and cured sausage production (Stark
2003). It is used for the surface treatment of almost every type
of cheese, either added as an emulsion for coating the cheese
rind or applied by dipping or spraying. Under these condi-
tions, PIM crystals remain on the surface of the product, and
the soluble fraction hardly penetrates (Stark 2003), thus not
interfering with the internal microorganisms that confer their
organoleptic properties to these products. Sausages are treated
with PIM by dipping or spraying to prevent fungal growth
during ageing.
Besides its major application on cheese and sausages, PIM
can also be used to prevent mould growth in yoghurt and other
dairy products such as unripened cheese (e.g. cream cheese,
cottage cheese and mozzarella) or whey protein cheese (e.g.
ricotta), also in dried uncooked meats and in iberico and pro-
sciutto hams. PIM can also be used to extend the shelf life of
different fruit and vegetable preparations, salad mixes, baking
products, sauces, fish, poultry, etc. (Fig. 2). Recently, PIM has
been used to successfully inhibit the growth of fungi during
natural black olive fermentation (Hondrodimou et al. 2011)
and to prevent carrot spoilage in refrigerated storage facilities
(de Vries et al. 2008).
Besides its direct application on foods, PIM has been suc-
cessfully incorporated into different packaging films/coatings
(de Oliveira et al. 2007; Pintado et al. 2010; Hanusová et al.
2010; Jiang et al. 2013b), including some that are edible
(Fajardo et al. 2010), where it has proven to be gradually
released over long periods of time, thus extending the shelf
life of the product. This ‘active packaging’ is receiving great
attention, since in several countries, there are restrictions on
the direct use of PIM with certain foods.
Beverages
PIM has also been described to be very effective for control-
ling growth of Aspergillus carbonarius, the fungus responsi-
ble for contamination of wine, grapes and grape juice with
ochratoxin A (one of the most abundant mycotoxins)
(Medina et al. 2007). PIM is used to prevent fungal spoilage
in other beverage products before their packaging, as it is
effective at low concentrations, it is stable if kept protected
from light and it is not affected by a wide range of pH values
(Juneja et al. 2012). Regulations vary from one country to
another but depending on the country; it may be used in fruit
juices, beer, wine, cider or iced tea (Mann and Beuchat 2008;
Siricururatana et al. 2013) (Fig. 2).
Pesticide
Furthermore, PIM is also used as a natural and safe product for
crop protection. It is used to control various fungal diseases
but especially basal rots on ornamental bulbs such as daffodils
that are caused by Fusarium oxysporum (Copping and Duke
2007). Its efficacy to control tomato gray mould disease
Fig. 2 Applications of PIM
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caused by Botrytis cinerea in greenhouse conditions has also
been reported (Lu et al. 2008). In 2012, it has been approved
as a biopesticide by the US Environmental Protection Agency
for its use in enclosed mushroom production facilities to pre-
vent dry bubble disease caused by Lecanicillium fungicola, a
devastating pathogen in the mushroom industry. Recently, its
efficacy controlling Aspergillus niger contamination in rice
leaffolder larvae (Cnaphalocrocis medinalis, a Lepidoptera
important for rice growth) mass-rearing facilities has been
reported (Su et al. 2014).
Other applications include its use in selective growthmedia
to prevent growth of yeast and filamentous fungi, such as in
the isolation of Brucella (Stack et al. 2002) or Legionella spp.
(Edelstein and Edelstein 1996).
Biosynthesis and export
PIM, like other macrocyclic polyketides, is synthesised by the
action of so-called type I modular polyketide synthases
(PKSs) (Aparicio et al. 2003) that sequentially assemble car-
bon chains from small acyl precursors, in a fashion that mech-
anistically resembles fatty acid biosynthesis. But, whereas in
fatty acid biosynthesis, each elongation step is followed by a
complete set of reactions including ketoreduction, dehydra-
tion and enoylreduction; in the synthesis of PIM and other
macrolides, the product of each decarboxylating condensation
may undergo all, some or none of the abovementioned mod-
ifications, thus resulting in alkanes, double bonds, hydroxyl
groups or ketones at defined positions of the polyketide chain.
Finally, a thioesterase domain located at the C-terminal end of
the last PKS (PimS4) releases the chain by lactonisation. Once
the first macrolide intermediate is formed (pimaricinolide), it
becomes the substrate of three functionalisation enzymes that
carry out specific oxidations and a glycosylation to yield the
final PIM molecule (see below).
Biosynthetic genes from S. natalensis were the first de-
scribed for a polyene macrolide (Aparicio et al. 1999), and
since then, the whole cluster responsible for the biosynthesis
of PIM (pim) from 12 acetate and one propionate units has
been thoroughly studied (Martín and Aparicio 2009)
(Table 1). The cluster from another PIM producer such as
S. chattanoogensis has been described later and named scn
(Du et al. 2011a). The cluster from S. natalensis is divided
into two subclusters which encode a highly complex PKS
distributed in five multifunctional polypeptides (PimS0 to
PimS4) harbouring 13 homologous sets of enzyme activities
(modules) and a total of 60 catalytic domains (Aparicio et al.
2000). The DNA region contains 15 additional open reading
frames which govern post-PKSmodification of the polyketide
skeleton, export and regulation of gene expression (Table 1).
Both clusters show a large degree of synteny. Compared
with the scn cluster, the pim cluster contains only two major
strain-specific differences, which correspond to pimH, an
efflux pump-encoding gene (Aparicio et al. 2000), and pimT
that encodes an amino acid exporter (Vicente et al. 2009) in-
volved in modulating PIM production via secretion of the PIM
inducer 2,3-diamino-2,3-bis(hydroxymethyl)-1,4-butanediol
(PI factor) (Recio et al. 2004). Both genes are located at the
two ends of the cluster (Table 1). In turn, the scn cluster con-
tains a putative transposase gene located downstream from
scnS1, the PKS in charge of the first elongation step in polyke-
tide construction. Interestingly, although the coding regions of
the two clusters are highly conserved, the intergenic regions are
much more variable, thus accounting for a different transcrip-
tional organisation between them (Du et al. 2011a) (Table 1).
The construction of PIM macrolide skeleton is initiated by
PimS0 and ends at PimS4 that thanks to its terminal
thioesterase domain releases the growing chain from the en-
zyme and cyclises it to yield a 26-membered macrocyclic
lactone (pimaricinolide) (Fig. 3). The fidelity of chain con-
struction has been demonstrated to be dependent on scnI
(the pimI orthologue from S. chattanoogensis). This discrete
thioesterase plays an important editing role in the selection of
starter acyl units and in the removal of aberrant extender units
during PIM biosynthesis (Wang et al. 2014a). It can be
complemented by other discrete thioesterases (Wang et al.
2014a), and it is conceivable that it could also have a comple-
mentary role with the terminal thioesterase domain of PimS4.
Once the aglycone is synthesised, a cytochrome P450 en-
zyme, pimG, was proposed to catalyse an oxidation of the
exocyclic methyl group at C12 via triple hydroxylations, to
form a carboxyl group, yielding 12-carboxypimaricinolide
(Martín andAparicio 2009). This hypothesis has recently been
proven by inactivation of pimG orthologue scnG form
S. chattanoogensis L10 (Liu et al. 2015b). Then, the amino
sugar mycosamine is attached to the macrocyclic aglycone at
C15 by the glycosyltransferase pimK to yield 4,5-
deepoxypimaricin (Fig. 3) (Mendes et al. 2005; Liu et al.
2015b), and finally, another P450 monooxygenase, pimD, ca-
talyses the last oxidation step to yield an epoxy group between
C4 and C5 from a double bond generated by the PKS (Mendes
et al. 2001, 2005). The X-ray structure of this latter P450 has
been resolved, both substrate-free and in complex with 4,5-
deepoxypimaricin (Kells et al. 2010).
The mycosamine sugar is synthesised from guanosine di-
phosphate (GDP)-mannose derived from fructose-6-phosphate
(Nic Lochlainn and Caffrey 2009). Inactivation of pimJ
orthologue amphDIII in the amphotericin-producing strain
S. nodosus resulted in accumulation of amphoteronolides dem-
onstrating that mycosamine is biosynthesised from GDP-
mannose (Byrne et al. 2003), and heterologous expression of
the orthologue from nystatin biosynthesis nysDIII has proven
that the first step in the mycosamine-specific pathway is carried
out by GDP-mannose 4,6-dehydratase (Nedal et al. 2007)
(Fig. 3). Thus, pimJ is proposed to catalyse conversion of
GDP-mannose to GDP-4-keto-6-deoxymannose, which
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presumably undergoes a spontaneous 3,4-isomerisation to give
GDP-3-keto-6-deoxymannose (Aparicio et al. 2003), the sub-
strate of the aminotransferase pimC for biosynthesis of GDP-3-
amino-3,6-dideoxymannose (GDP-mycosamine). Finally, the
glycosyltransferase pimK catalyses the attachment of
mycosamine to the pimaricinolide (Mendes et al. 2005).





pimT PIM inducer PI factor secretion A
pimM PAS-LuxR regulator scnRII
pimR SARP-LAL regulator scnRI
pimK Mycosamine transferase scnK
pimS4 PKS Extension module 12, cyclisation and chain release scnS4
pimS3 PKS Extension module 11 scnS3
pimS2 PKS Extension modules 5-10 scnS2
pimI Thioesterase (type II) scnI
pimJ GDP-mannose 4,6-dehydratase scnJ
pimA ABC transporter (PIM export) scnA
pimB ABC transporter (PIM export) scnB
pimE Cholesterol oxidase scnE
pimC GDP-3-keto-6-deoxymannose aminotransferase scnC
pimG P450 monooxygenase (C12 hydroxylase) scnG
pimF Ferredoxin scnF
pimS0 PKS Loading module scnS0
pimL Tyrosine phosphatase scnL
A Transposase tnp
pimS1 PKS Extension modules 1-4 scnS1
pimD P450 monooxygenase (C4,5 epoxidase) scnD
pimH PIM efflux pump A
Arrows indicate the organization of transcriptional units. A = absent
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Due to its mode of action, PIM does not have any antibacte-
rial activity and thus should not represent a threat to the produc-
ing organism; however, its accumulation inside the cell may be
harmful, which suggests that producing organisms should en-
sure an active efflux. The products of three genes in the cluster
might be involved in PIM export in S. natalensis. Two of them
belong to type III ATP-binding cassette (ABC) transporter pro-
teins, which combine both ATPase and transmembrane domains
within the same polypeptide (Mendez and Salas 2001). These,
pimA and pimB, are thought to associate forming a heterodimer
(Aparicio et al. 2003), and their role in PIM secretion has been
deduced upon inactivation of the pimA and pimB homologues,
nysH and nysG, which encode the nystatin ABC heterodimer
transporter. Suchmutants still exported some amount of nystatin,
suggesting the existence of alternative transport systems for this
antifungal antibiotic (Sletta et al. 2005). Such alternative trans-
port system, in the case of PIM, could be constituted by the
putative efflux pump encoded by pimH (Aparicio et al. 2000).
Metabolic engineering and semi-synthetic derivatives
In the search for improvement of PIM properties, a good num-
ber of semi-synthetic derivatives have been described in the
literature, including esters (Bonner et al. 1972; Falkowski
et al. 1979), N,N-dialkyl (Paquet and Carreira 2006), N-alkyl
(Suloff et al. 2003), N-acyl (Nirgudkar et al. 1988), N-glycosil
(Falkowski et al. 1980), N-aryl (Belakhov et al. 2010) and
hydrophosphoryl derivatives (Belakhov et al. 2008), amongst
others. Liposomal preparations have been also studied
(Bouaoud et al. 2015).
Moreover, the knowledge of PIM biosynthetic pathway, and
the development of an efficient conjugation system for
S. natalensis (Enríquez et al. 2006), has allowed the generation,
by genetic manipulation, of a number of less toxic or more
water-soluble derivatives (Caffrey et al. 2008; Kong et al. 2013).
The first PIM derivative obtained by genetic engineering of
S. natalens is was i ts immediate precursor, 4 ,5-
deepoxypimaricin (DEP) (Mendes et al. 2001). This was ob-
tained by disruption of pimD, the gene encoding the cyto-
chrome P450 monooxygenase responsible for epoxidation at
C4-C5 that constitutes the last step of PIM biosynthesis
(Mendes et al. 2005; Kells et al. 2010). This compound showed
a clear decrease in antifungal activity, thus highlighting the
importance of the epoxide group in the interaction of PIM with
the fungal membrane. Recently, it has been shown that DEP
can be accepted as a substrate by nysL, the pimD homologue
Fig. 3 Biosynthesis of PIM. Each circle represents an enzymatic
domain. ACP acyl carrier protein, AT acyltransferase, CoL carboxylic
acid:CoA ligase, DH ß-hydroxyacyl-thioester dehydratase, KR ß-
ketoacyl-ACP reductase, KS ß-ketoacyl-ACP synthase, and TE
thioesterase. The KR domain in black (module 9) is predicted to be
inactive. The AT in module 7 (grey) is predicted to incorporate a
propionate extender unit. Biosynthetic pathway for mycosamine is also
included. The isomerisation step is thought to be spontaneous
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responsible for the introduction of the last hydroxylation in the
biosynthesis of nystatin (Volokhan et al. 2006), thus generating
6-hydroxy-4,5-deepoxypimaricin (6-OH-DEP) (Santos-
Aberturas et al. 2015), which does not show an improvement
in antifungal activity compared to DEP. Additionally, it has
been shown that both DEP and 6-OH-DEP can undergo
carboxamidation reactions catalysed by the amidotransferase
PscA, thus resulting in carboxamidated derivatives
(4,5-deepoxy-AB-400 and 6-hydroxy-4,5-deepoxy-AB-400,
respectively; see Fig. 4) exhibiting improved antifungal activity
in comparison with their carboxylated precursors (Santos-
Aberturas et al. 2015). PscA and its homologous protein,
PscB, are responsible for the natural occurrence of tetraene
carboxamidated compounds (Seco et al. 2005, 2010; Miranzo
et al. 2010), including AB-400, the PIM carboxamidated deriv-
ative (Cañedo et al. 2000). PscA has shown a much broader
substrate that scope PscB, a fact that makes it a stronger candi-
date for the development of future polyene derivatives (Seco
et al. 2010; Santos-Aberturas et al. 2015).
The recent manipulation of the PIM biosynthetic pathway
in S. chattanoogensis has led to the production of new PIM
derivatives by knocking out scnG, which encodes the P450
monooxygenase (homologous to pimG) proposed to be
responsible for the formation of the carboxyl exocyclic group
(Martín and Aparicio 2009) (Fig. 3). This gene disruption re-
sulted in the accumulation of 4,5-deepoxy-12-decarboxy-12-
methyl PIM, thus indicating that glycosyltransferase scnK is
able to add themycosaminemoiety to the decarboxylated agly-
cone whilst scnD is unable to introduce the epoxide group
(Fig. 3) (Liu et al. 2015b). In contrast, the inactivation of the
same gene by Qi et al. (2015) resulted in accumulation of
12-decarboxy-12-methyl PIM in addition to that of 4,5-
deepoxy-12-decarboxy-12-methyl PIM (Fig. 4), thus suggest-
ing that scnD might be able to introduce the epoxide group to
some extent. 12-Decarboxy-12-methyl PIM might be interest-
ing since it shows decreased haemolytic effects together with a
twofold increase of the original PIM antifungal activity levels
(Qi et al. 2015). These authors have also characterised the
bioactivity of 4,5-deepoxy-12-decarboxy-12-methyl PIM,
showing that it maintains the PIM antifungal activity whilst
exhibiting a decreased haemolytic effect. Interestingly, the mu-
tant obtained by Qi et al. (2015) also accumulated the non-
antifungal and non-haemolytic 2-hydro-3-hydroxy-4,5-
deepoxy-12-decarboxy-12-methyl PIM (Fig. 4), suggesting
that the scnG-catalysed carboxylation might occur during the
PKS assembly and not after it. In addition, the disruption of
Fig. 4 PIM derivatives obtained by metabolic engineering of the biosynthetic gene cluster. The grey circles highlight structural differences from the
original PIM molecule
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scnK in S. chattanoogensis (Liu et al. 2015a, b) led to the
accumulation of the 4,5-deepoxypimaricinolide aglycone
(Fig. 4), which shows no antifungal activity by itself but could
constitute an interesting scaffold for the introduction of alter-
native sugar moieties by semi-synthetic, mutasynthetic or pro-
tein engineering approaches. The accumulation of that inter-
mediate supports the idea that scnG (pimG) acts before the
glycosylation step in the PIM biosynthetic pathway (Fig. 3).
Regulation
As occurs with most secondary metabolites synthesised by
Streptomyces, PIM production takes place in a growth-
dependent manner and is governed by complex regulatory
networks that respond to population density and a variety of
environmental and physiological signals (van Wezel and
McDowall 2011; Liu et al. 2013). One of the key players of
these networks is transcriptional regulation.
Transcriptional control by cluster-situated regulators
Transcriptional regulation is a complex process involving
multiple signals and an intricate network of regulators that
cross talk with each other. Typically, the lowest level is played
by so-called pathway-specific transcriptional regulators,
which are encoded within the respective biosynthetic gene
clusters. Two transcriptional regulators are encoded by the
PIM gene cluster, pimR and pimM.
PimR was the first pathway-specific transcriptional regula-
tor of PIM biosynthesis to be described and also the first of its
class (Antón et al. 2004). It is a transcriptional activator
(knockout mutants fail to produce PIM) with a peculiar archi-
tecture. It combines an N-terminal streptomyces antibiotic r-
egulatory protein (SARP) DNA-binding domain with a C-
terminal half homologous to guanylate cyclases and large
ATP-binding regulators of the LuxR family (LAL) (Antón
et al. 2004). The C-terminal half includes the ATP/GTP-
binding domain characteristic of these protein families but
lacks the characteristic signature sequence at the N-terminus
of guanylate cyclases or the LuxR-type helix-turn-helix
(HTH) motif for DNA-binding present at the C-terminus of
LAL regulators (Guerra et al. 2012). Recently, we have
characterised pimRmode of action by means of electrophoret-
ic mobility shift assays (EMSAs), DNaseI protection studies,
reverse transcription quantitative PCR (RT-qPCR) and gene
promoter replacement experiments and determined that it
binds a single operator that contains three heptameric direct
repeats of the consensus CGGCAAG with 4-bp spacers
(Santos-Aberturas et al. 2012). Such operator lies in the pro-
moter region of pimM, whose expression is activated upon
pimR binding. Interestingly, the binding sequence of pimR
(TGGCAAGAAAGCGGCAGGTGTTCGGCAAG) is exact-
ly conserved in the intergenic region between scnRII and
scnRI in the scn gene cluster of S. chattanoogensis (pimM
and pimR counterparts, respectively (Du et al. 2011a)) and
also between pteF and pteR, the corresponding counterparts
in the filipin gene cluster of S. avermitilis, including the inter-
heptamer nucleotides.
Regulators with a similar architecture include the
orthologues pteR and filR involved in filipin biosynthesis in
S. avermitilis (Ikeda et al. 2003) and S. filipinensis, respective-
ly (Payero et al. 2015), but also regulators of peptidyl nucle-
oside antibiotic biosynthesis such as nikkomycins (sanG) and
polyoxins (polR) (Liu et al. 2005; Li et al. 2009). Filipin is a
pentaene macrolide, whilst nikkomycins and polyoxins are
peptidyl nucleoside antibiotics. Interestingly, all these com-
pounds are effective antifungals, and it has been speculated
that the domain arrangement of these regulatory proteins
might be related with the detection of common signals in-
volved in the triggering of antifungal production (Santos-
Aberturas et al. 2012). Noteworthy, the consensus heptamer
for pimR is identical to those of sanG (He et al. 2010) and polR
(Li et al. 2009), although in these cases, only two heptameric
repeats are present in the operator.
PimM was the second transcriptional activator of PIM bio-
synthesis to be described (PIM production is abolished in
deleted mutants) (Antón et al. 2007). It also has a peculiar
architecture, combining an N-terminal PAS sensory domain
(Hefti et al. 2004) with a C-terminal helix-turn-helix motif of
the LuxR type for DNA binding (Santos et al. 2012). The PAS
domain detects a physical or chemical stimulus and regulates,
in response, the activity of the effector domain (Möglich et al.
2009). Unlike most other sensors, proteins containing PAS
domains are located in the cytosol, and therefore, they detect
internal signals, but they can also sense environmental factors
that cross the cell membrane. In contrast with the majority of
prokaryotic PAS domain-containing regulators, which are
sensor kinases of two-component systems (Taylor and
Zhulin 1999), pimM does not belong to a two-component
system. Recently, we have characterised the mode of action
of pimM at the molecular level, and determined the canonical
binding site of this regulator as CTVGGGAWWTCCCBAG,
just at the −35 hexamer of regulated promoters in S. natalensis
(Santos-Aberturas et al. 2011b). The pimM paradigm is par-
ticularly attractive because homologous regulatory proteins
have been found to be encoded in all known biosynthetic gene
clusters of antifungal polyenes, and they have been shown to
be functionally equivalent, to the extent that the production of
PIM is restored in S. natalensis ΔpimM upon introduction of
heterologous regulators of the PAS-LuxR class, such as
amphRIV (amphotericin), nysRIV (nystatin) or pteF (filipin)
into the strain (Santos-Aberturas et al. 2011b). Furthermore,
introduction of a single copy of pimM into the amphotericin-
producing strain S. nodosus, into the filipin-producing strain
S. avermitilis or into the rimocidin-producing strain S. rimosus
boosted the production of all polyenes, thus indicating that
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these regulators are fully exchangeable (Santos-Aberturas
et al. 2011b). PimR and pimM act in a hierarchical way,
pimR binds pimM promoter and activates its transcription
(Santos-Aberturas et al. 2012) and the gene product of the
latter activates transcription from eight different promoters
of PIM structural genes directly (Santos-Aberturas et al.
2011a) (Fig. 5).
Although pimM has been traditionally considered as a
PIM-specific regulator, recent results have shown that it can-
not be considered as pathway-specific but as a regulator with a
wider range of implications. Its canonical operator was used to
search for putative targets of orthologous protein pteF in the
genome of S. avermitilis, finding 101 putative operators, 97
outside the pentaene filipin gene cluster (pte). These binding
sites were located inside or upstream from genes involved in
different aspects of both primary and secondary metabolism,
including genetic information processing, DNA replication
and repair, energy metabolism, carbohydrate metabolism, lip-
id metabolism, morphological differentiation, transcriptional
regulation and secondary metabolite biosynthesis, amongst
others (Fig. 5), thus suggesting that the regulator could govern
those processes. Seventeen of these operators were selected,
and their binding to pimM DNA-binding domain was demon-
strated by EMSA (Vicente et al. 2015). As a proof of concept,
the biosynthesis of the ATP-synthase inhibitor oligomycin
whose gene cluster included two operators was studied.
PteF mutants, which show a severe loss of filipin production
and delayed spore formation in comparison to that of the wild-
type strain (Vicente et al. 2014), also showed a severe loss of
oligomycin production and reduced expression of olm genes,
whereas gene complementation of the mutant restored pheno-
type, thus demonstrating that pteF was able to co-regulate the
biosynthesis of two related secondary metabolites, filipin and
oligomycin. This cross regulation could therefore be extended
to all the processes indicated above, which suggests that PAS-
LuxR regulators affect a plethora of processes previously
unforeseen.
Global regulatory mechanisms
The biosynthesis of PIM in S. natalensis is very sensitive to
repression by inorganic phosphate. Concentrations as low as
2 mM are sufficient to block PIM production. This negative
effect is exerted at the transcription level (Mendes et al.
2007b). The cellular response to phosphate scarcity is driven
by the two-component system phoR-phoP. PhoR is a
membrane-bound sensor kinase, and phoP is a DNA-
binding response regulator that controls transcription of target
genes known as the pho regulon. DNA binding of phosphor-
ylated phoP to its operators (PHO boxes) takes place follow-
ing phosphate depletion. The phoU-phoR-phoP region of
S. natalensis has been characterised (Mendes et al. 2007b).
The phoP protein from S. coelicolor binds to PHO box con-
sensus sequences in the S. natalensis phoU-phoRP intergenic
Fig. 5 Model of PIM regulation.
Proposed model for gene
expression activation by the
cluster-situated regulators pimR
and pimM. The pointed boxes
indicate the direction of
transcription of pim genes. The
transcriptional regulators are
indicated in red, the PKS genes
are shown in green and the
remaining genes in orange.
Dashed lines represent
transcription and translation of
regulatory genes. Numbers
indicate the order of events.
Continuous black arrows indicate
direct transcriptional activation,
whereas the dotted arrow
indicates indirect activation. Bent
arrows below the genes indicate
transcriptional units. The blue line
indicates other processes directly
affected by pimM (Vicente et al.
2015)
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region, indicating that the system is autoregulated. Several
pim genes showed increased expression in the phoP-disrupted
mutant, but no consensus PHO boxes were found in the whole
pim cluster, suggesting that phosphate control of these genes is
mediated by phoP via other regulators.
Another pleiotropic regulator which positively regulates
PIM production by direct binding to the promoters of struc-
tural genes has been described in S. chattanoogensis. WhiG
binds to the promoters of scnC and scnD (homologues to
pimC and pimD, respectively) (Liu et al. 2015a). This regula-
tor also acts as an activator of scnRI and scnRII transcription
(orthologues of pimR and pimM, respectively), although in
this case indirectly (Liu et al. 2015a).
Other wide domain regulators that have been involved in
indirect PIM regulation are the adpA pleiotropic regulator,
which has been shown to act as a positive regulator of PIM
production in S. chattanoogensis (Du et al. 2011a), and one of
its direct targets wblA (Yu et al. 2014).
PIM production is an aerobic process and thus positively
affected by oxygen availability. However, high levels of mo-
lecular oxygen consumption can lead to the formation of re-
active oxygen species (ROS) that can damage cell compo-
nents. The redox-based regulation network triggered by an
imbalance of the intracellular ROS homeostasis, in particular
intracellular H2O2 levels, is also able to modulate the biosyn-
thesis of PIM in S. natalensis (Beites et al. 2011). Inactivation
of superoxide dismutase sodF leads to reduced PIM produc-
tion, whilst suppression of the H2O2-detoxifying enzymes like
the alkyl hydroperoxidase system ahpCD or the catalase
katA1 provokes a PIM overproducer phenotype (Table 2), thus
suggesting a positive correlation between intracellular H2O2
and PIM production (Beites et al. 2011). Recently, a cross talk
between phosphate metabolism and oxidative stress in
S. natalensis has been unveiled by transcriptome analysis.
Deletion of either sodF or ahpCD causes a delay on the tran-
scriptional activation of the pim cluster, most likely attribut-
able to a delay on Pi exhaustion in the culture broth.
Additionally, these authors have identified cellular NADPH/
NADH ratio and the availability of biosynthetic precursors via
the branched chain amino acid metabolism as the main PIM
biosynthetic bottlenecks under oxidative stress conditions
(Beites et al. 2014).
Quorum-sensing signals
Quorum sensing is a communication mechanism that allows
bacteria to detect a high density of population and react by
different mechanisms of adaptation. Growing cells produce
extracellular signals (often called autoinducers) that are detect-
ed by the remaining cells of the culture, which in turn respond
to this stimulus by the transcription or repression of given
genes. In Streptomyces sp., both morphological differentiation
and secondary metabolite biosynthesis are controlled by
quorum-sensing signals that act at nanomolar concentrations.
Streptomyces use γ-butyrolactones (2,3-di-substituted-γ-
butyrolactones) (GBL) as autoinducers (Fig. 6), and the signal
transduction is mediated by the interaction of these
autoregulators with cognate receptors which causes the recep-
tor to dissociate from the DNA,which in turn allows transcrip-
tion of the target genes. Thus, GBL receptors are transcrip-
tional regulators belonging to the tetR superfamily of tran-
scriptional factors (Gottelt et al. 2012).
GBL receptor proteins have been reported in S. natalensis
(sngR) (Lee et al. 2005) and in S. chattanoogensis (scgR) (Du
et al. 2011b). A GBL receptor homologue, sprA, has also been
described in S. chattanoogensis (Zhou et al. 2015). Both sngR
and sprA, but not scgR, have been described to act as positive
regulators of both antifungal production and morphological
differentiation (Lee et al. 2005; Zhou et al. 2015). Typically,
a gene located immediately upstream and divergently from the
GBL receptor encoding gene codes for the GBL synthase.
Such situation has been described also in S. natalensis
(sngA) (Lee et al. 2008) and S. chattanoogensis (scgA) (Du
et al. 2011b). In the case of S. chattanoogensis, the product of
a second gene immediately downstream from scgA, scgX, is
also involved in GBL biosynthesis (Du et al. 2011b). The
inactivation of either of the synthases sngA or scgA leads to
a decrease in PIM production and a delay in morphological
differentiation (Lee et al. 2008; Zhou et al. 2015) that has to be
attributed to a reduction of a putative GBL in the cells.
However, a true GBL was never found in S. natalensis
(Recio et al. 2004) or S. chattanoogensis (Du et al. 2011b).
In S. natalensis, although we have not been able to detect
any GBL, we discovered an inducing compound of a novel
class (PI factor; 2,3-diamino-2,3-bis(hydroxymethyl)-1,4-
butanediol) (Fig. 6) (Recio et al. 2004). PI factor elicits
polyene production in S. natalensis mutants that had lost
their ability to produce PIM at nanomolar concentrations
in a manner characteristic of quorum sensing (Recio et al.
2004). The compound is exported out of the cells by the
amino acid exporter pimT, and in contrast to GBLs, it is
thought to be recognised at the membrane level and not
intracellularly (Vicente et al. 2009). However, the exact
mechanism remains unknown. Studies of PI factor have
been limited by access to pure preparations of the com-
pound. Recently, a chemical synthesis method has been re-
ported (Morin and Sello 2010) that will permit future stud-
ies. Interestingly, S. natalensis seems to be able to integrate
different quorum signals since A-factor from S. griseus
(a well-known autoregulator of the GBL class) also triggers
PIM production in the mutants (Recio et al. 2004).
Glycerol, ethylene glycol and 1,2 or 1,3-propanediol (Fig. 6)
have also been described to elicit the production of PIM in
S. natalensis although at higher concentrations than PI factor
(Recio et al. 2006). Interestingly, glycerol also stimulated the
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production of seven different polyene macrolides by their re-
spective producer strains, including S. noursei (nystatin),
S. rimosus (rimocidin), S. griseus (candicidin), S. filipinensis
(filipin), S. albulus (tetrafungin), S. eurocidicus (eurocidin) and
S. cinnamoneum (fungichromin). Although the exact mecha-
nism remains unknown, the action of glycerol seems to be
independent of PI factor-inducing effect (Recio et al. 2006).
Cholesterol oxidase
All the gene clusters for small-sized polyenes described up to
date contain a cholesterol oxidase-encoding gene. These are
pimE and scnE in the case of PIM (Aparicio et al. 2000; Du
et al. 2011a), tetrO in the case of tetramycin (Cao et al. 2012),
pteG and filG in the case of filipin (Ikeda et al. 2003; Payero
et al. 2015) and rimD in the case of rimocidin/CE-108 (Seco
et al. 2004). Cholesterol oxidases (3b-hydroxysterol oxidases;
EC 1.1.3.6) are flavoproteins that catalyse both the oxidation
of cholesterol to 5-cholesten-3-one with the reduction of mo-
lecular oxygen to hydrogen peroxide and the isomerisation of
the Δ5 bond to yield 4-cholesten-3-one as the final product.
This enzyme participates in the initial step in the degradation
of cholesterol (or other sterols with a 3-β-hydroxyl group) as a
carbon and energy source for growth of different bacteria but
Table 2 PIM production
improvement strategies and yield Strategy Strain Yield (%) Reference
PimM overexpression (NP) S. natalensis 240 Antón et al. 2007
ScnRII overexpression (NP) S.chattanoogensis 460 Du et al. 2009
SlnM overexpression (NP) S. lydicus 190 Wu et al. 2014
SlnM overexpression (ermE*P) S. lydicus 240 Wu et al. 2014
SlnM overexpression (NP + ermE*P) S. lydicus 300 Wu et al. 2014
SngA overexpression (NP) S. natalensis 170 Lee et al. 2008
WblA overexpression (ermE*P) S.chattanoogensis 130 Yu et al. 2014
WhiG overexpression (ermE*P) S.chattanoogensis 126 Liu et al. 2015a
SchPPT overexpression (ermE*P) S.chattanoogensis 140 Jiang et al. 2013a, b
SngR deletion S. natalensis 460 Lee et al. 2005
PhoRP deletion S. natalensis 180 Mendes et al. 2007b
AhpCD deletion S. natalensis 130 Beites et al. 2011
KatA1 deletion S. natalensis 156 Beites et al. 2011
Glycerol addition (100 mM) S. natalensis 250 Recio et al. 2006
Pi factor addition (300 nM) S. natalensis 133 Recio et al. 2004
Acetate:propionate addition (7:1) (2 g/L) S. natalensis 250 Elsayed et al. 2013
Propanol addition (0.2 %) S. natalensis 117 Li et al. 2014
Genome shuffling S. gilvosporeus 197 Luo et al. 2012
Integration of vgb gene S. gilvosporeus 407 Wang et al. 2014b
Aspergillus niger extracellular extract S. natalensis 250 Wang et al. 2013
Penicillium chrysogenum extracellular extract S. natalensis 300 Wang et al. 2013
The maximum yield is indicated
NP native promoter
Fig. 6 Quorum-sensing signals
involved in PIM biosynthesis
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had no obvious role in antifungal production (Aparicio and
Martín 2008).
In S. natalensis, functional analysis studies led to the sur-
prising finding that pimE is essential for the biosynthesis of
PIM. This extracellular enzyme, or other cholesterol oxidases,
was shown to restore PIM production when added to knock-
out mutant culture broths or ‘resting cells’ (Mendes et al.
2007a). Hence, it has been proposed that these enzymes could
act as fungal sensors, probably via ergosterol detection and in
response trigger, by an unknown mechanism, antifungal pro-
duction. This would confer a selective advantage on the pro-
ducing organisms, which are soil dwellers, against their fungal
competitors with ergosterol-containing membranes (Aparicio
and Martín 2008).
Production improvement strategies
At industrial scale, PIM is produced by fermentation, which
requires microbial strains producing high titres of the com-
pound. Given that wild-type strains isolated from nature pro-
duce only discrete amounts of PIM, this implies the need for
production improvement to meet commercial requirements.
This has been traditionally achieved by sequential rounds of
random mutation and selection, but the knowledge gained
during the last years has provided new tools for a more ratio-
nal way of yield improvement.
Different approaches have been used to increase PIM pro-
duction yield. These studies include optimisation of medium
composition (Farid et al. 2000; Chen et al. 2008), improve-
ment of cultivation conditions (El-Enshasy et al. 2000; Liang
et al. 2008) and strain gene manipulation. One of the most
straightforward ways to improve metabolite production by
gene manipulation is the overexpression of poorly expressed
activators, and that turned out to be the case of pimM in
S. natalensis. Gene dosage increment of pimM by using inte-
grative vectors resulted in increased PIM production, thus
suggesting that its expression constitutes a bottleneck for an-
tifungal production (Antón et al. 2007). Moreover, PAS-LuxR
regulators are functionally equivalent, to the extent that intro-
duction of a single copy of pimM (or other PAS-LuxR regu-
lator) into the chromosome of a given polyene producer
boosts the production of the corresponding polyene (Santos-
Aberturas et al. 2011b). These findings constituted the first
report of a general mechanism regulating polyene production,
and established the rationale for enhancement of PIM, and
other polyene production in different producers of these anti-
fungals (Du et al. 2009; Wei et al. 2011; Wu et al. 2014).
Improvement in production varied between strains and the
production medium used but ranged from 40% in the
rimocidin producer S. rimosus (Santos-Aberturas et al.
2011b) to 460% in the PIM producer S. chattanoogensis (Du
et al. 2009) (Table 2). These strategies for production im-
provement have used the native promoter of the PAS-LuxR
gene, but the use of constitutive promoters such as ermE*p
instead of the original promoter, and in addition to the native
promoter (double promoter), have also been described with
improved results (Wei et al. 2011; Wu et al. 2014).
Other strategies reported for production improvement have
included the overexpression of phosphopantetheinyl transfer-
ases (Jiang et al. 2013a, b), the GBL synthase sngA (Lee et al.
2008) and pleiotropic regulators such as whiG (Liu et al.
2015a) or wblA (Yu et al. 2014) or deletion of the two-
component system phoRP (Mendes et al. 2007b) and the
GBL receptor sngR (Lee et al. 2005) (Table 2).
The addition of short-chain carboxylic acids has also been
reported to increase PIM yield and also to shorten production
time. Acetic and propionic acids were particularly stimulatory
in S. natalensis cultures, especially when added together in a
7:1 ratio (total concentration 2 g/L) (Elsayed et al. 2013). This
makes sense since these compounds are precursors of polyke-
tide biosynthesis. Similarly, propanol has also been reported
as stimulatory (Li et al. 2014) (Table 2).
Other successful strategies used included genome shuffling
by recursive protoplast fusion, reaching increments of 97% in
comparison with the parental strain (Luo et al. 2012), the
chromosomal integration of the Vitreoscilla hemoglobin vgb
gene, which rendered a maximum of 407 % increase depend-
ing on the growth conditions (Wang et al. 2014b), or the use of
fungal elicitors present in extracellular extracts of A. niger and
in particular of P. chrysogenum (Wang et al. 2013) (Table 2).
Prospects
Amongst the major applications of PIM, its use as a natural
food antimicrobial is generalised worldwide, being used in
more than 150 countries. PIM has been used for more than
40 years now and continues to constitute a gold standard in the
preservation of foods and beverages against mould spoilage
and the inherent risk of mycotoxin poisoning. Its broad spec-
trum of activity against almost every type of fungi but not
bacteria, its lack of effect on the quality of food, its low like-
lihood of causing microbial resistance and especially its safe-
ness for consumption have made this molecule an ideal
biopreservative. Thus, its use that was initially restricted to
the surface treatment of some types of cheese has expanded
exponentially to other foods, beverages, storage facilities and
even some crops. Furthermore, the increasing demand of
healthy processed foods and beverages with natural antimicro-
bials as alternatives to physical- and chemical-based antimi-
crobial treatments ensures that PIM use will continue growing
in the future.
Thanks to the advances in the genetic manipulation of PIM
producers and the considerable progress in the knowledge
about the regulation of PIM production; several PIM deriva-
tives with improved properties have been developed, and
many of the bottlenecks hampering PIM production at high
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titres have been overcome. The future application of this
knowledge at the industrial scale will hopefully permit to sat-
isfy the growing PIM commercial demands. In this sense, the
present availability of the genome sequences of PIM pro-
ducers such as S. natalensis (GenBank JRKI01; Beites et al.
2015) and S. chattanoogensis (GenBank LGKG01) will cer-
tainly constitute a very valuable tool in the efforts to improve
PIM production.
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